GNC-038 Injection

GNC-038 · Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GNC-038 Injection, covering 2025-09-26 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]